20-hydroxyecdysone clinical trials

SARA-31: A phase 3 trial to evaluate the efficacy and safety of BIO-101 in elderly patients suffering from severe SARcopeniA: an interventional, randomized double-blind placebo- controlled, clinical trial.

This study, called SARA-31, is looking at a new medication, BIO-101, for older people with a muscle weakening condition called sarcopenia. It aims to see if BIO-101 can help prevent serious problems with moving around, compared to a dummy pill. It's a key stage in testing this new treatment.